Generic drugmakers Teva and Sandoz make major push to biosimilars

By Natalie Grover and Steven Scheer (Reuters) - Generic drug makers Teva Pharmaceutical Industries and Sandoz say they are planning a significant ramp...

Related Keywords

Jerusalem ,Israel General ,Israel ,Japan ,United States ,Switzerland ,London ,City Of ,United Kingdom ,Japanese ,America ,Swiss ,Michele Gershberg ,Pierre Bourdage ,Steven Scheer ,Sven Dethlefs ,Natalie Grover ,Claire Dabreu ,Joshua Harris ,Suzanne Goldenberg ,Amgen ,Drug Administration ,Duke University Margolis Center ,Novartis ,Reuters ,Pfizer Inc ,Abbvie Inc ,Teva Pharmaceutical Industries ,Barclays ,Israeli Based Teva ,Claired Abreu Hayling ,North America ,Chief Operating Officer Pierre ,Burford Capital ,Duke University ,Margolis Center ,Duke Report , ,